Your browser doesn't support javascript.
loading
Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial.
Goldberg, Sarah B; Gettinger, Scott N; Mahajan, Amit; Chiang, Anne C; Herbst, Roy S; Sznol, Mario; Tsiouris, Apostolos John; Cohen, Justine; Vortmeyer, Alexander; Jilaveanu, Lucia; Yu, James; Hegde, Upendra; Speaker, Stephanie; Madura, Matthew; Ralabate, Amanda; Rivera, Angel; Rowen, Elin; Gerrish, Heather; Yao, Xiaopan; Chiang, Veronica; Kluger, Harriet M.
Afiliação
  • Goldberg SB; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA. Electronic address: sarah.goldberg@yale.edu.
  • Gettinger SN; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Mahajan A; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Chiang AC; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Herbst RS; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Sznol M; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Tsiouris AJ; New York Presbyterian Hospital, Weill Cornell Medical Center, New York, NY, USA.
  • Cohen J; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Vortmeyer A; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Jilaveanu L; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Yu J; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Hegde U; University of Connecticut Health Center, Farmington, CT, USA.
  • Speaker S; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Madura M; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Ralabate A; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Rivera A; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Rowen E; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Gerrish H; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Yao X; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Chiang V; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
  • Kluger HM; Yale University School of Medicine and Yale Cancer Center, New Haven, CT, USA.
Lancet Oncol ; 17(7): 976-983, 2016 Jul.
Article em En | MEDLINE | ID: mdl-27267608
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares / Melanoma / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma Pulmonar de Células não Pequenas / Anticorpos Monoclonais Humanizados / Neoplasias Pulmonares / Melanoma / Antineoplásicos Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article